NewGen Therapeutics Inc.
This article was originally published in Start Up
Executive Summary
NewGen Therapeutics Inc. aims to exploit weaknesses in the intellectual property protecting certain cancer drugs that already are blockbusters or that appear destined to be highly successful in coming years. The plan is to create functionally improved versions of valuable cancer drugs and develop them as treatments for specific subsets of patients likely to respond well.